AIV
34
-2
AFL
44
-5
DTE
42
-5
ALLE
53
-7
NVDA
59
3
TXN
48
-7
IFF
51
-5
MSFT
48
4
HBAN
82
-3
VZ
40
-4
CHD
24
-5
VRSK
32
-5
RL
70
-2
PPL
62
-5
DVN
40
-4
SWK
65
-6
GILD
55
5
PH
75
-3
HPE
56
-8
TXT
69
-3
AIV
34
-2
AFL
44
-5
DTE
42
-5
ALLE
53
-7
NVDA
59
3
TXN
48
-7
IFF
51
-5
MSFT
48
4
HBAN
82
-3
VZ
40
-4
CHD
24
-5
VRSK
32
-5
RL
70
-2
PPL
62
-5
DVN
40
-4
SWK
65
-6
GILD
55
5
PH
75
-3
HPE
56
-8
TXT
69
-3
Financhill
Back

WisdomTree Emerging Markets SmallCap Dividend Fund Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
70

DGS
WisdomTree Emerging Markets SmallCap Dividend Fund

Last Price:
$58.06
Seasonality Move:
3.33%
Sell
36

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Buy
70
WisdomTree Emerging Markets SmallCap Dividend Fund (DGS) is a Buy

Is WisdomTree Emerging Markets SmallCap Dividend Fund a Buy, Sell or Hold?

  • The current WisdomTree Emerging Markets SmallCap Dividend Fund [DGS] share price is $58.12. The Score for DGS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • DGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DGS Stock Price Chart

What is WisdomTree Emerging Markets SmallCap Dividend Fund's stock price today?

  • The WisdomTree Emerging Markets SmallCap Dividend Fund share price today is $58.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

DGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 60.99 Buy
Chaikin Money Flow: 34854 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.75 Buy
20-day SMA: 57.29 Buy
50-day SMA: 56.99 Buy
200-day SMA: 54.87 Buy
8-day EMA: 57.87 Buy
20-day EMA: 57.46 Buy
50-day EMA: 57.13 Buy
200-day EMA: 55.32 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

WisdomTree Emerging Markets SmallCap Dividend Fund Earnings Growth & DGS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

WisdomTree Emerging Markets SmallCap Dividend Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):